American Society of Nephrology: Lipid Combo Cuts CV Risk in Kidney Disease, Oxford University Study

MedPageToday -- DENVER -- Patients with chronic kidney disease but no history of heart disease had a significantly lower risk of major vascular events when treated with lipid-lowering therapy, data from a randomized clinical trial showed.